LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
Hs 578T Erlotinib
10
uM
LJP5
0.6137 0.0280 0.5858 0.0421
Hs 578T Gefitinib
0.04
uM
LJP6
0.9991 0.0057 0.9989 0.0056
Hs 578T Gefitinib
0.12
uM
LJP6
0.9835 0.0028 0.9844 0.0021
Hs 578T Gefitinib
0.37
uM
LJP6
0.9854 0.0088 0.9844 0.0089
Hs 578T Gefitinib
1.11
uM
LJP6
0.9865 0.0065 0.9858 0.0079
Hs 578T Gefitinib
3.33
uM
LJP6
0.9865 0.0020 0.9870 0.0020
Hs 578T Gefitinib
10
uM
LJP6
0.8493 0.0097 0.8495 0.0089
Hs 578T Nilotinib
0.04
uM
LJP5
1.0939 0.0288 1.0922 0.0326
Hs 578T Nilotinib
0.12
uM
LJP5
1.0956 0.0391 1.0954 0.0414
Hs 578T Nilotinib
0.37
uM
LJP5
1.0895 0.0430 1.0908 0.0453
Hs 578T Nilotinib
1.11
uM
LJP5
1.0674 0.0317 1.0689 0.0345
Hs 578T Nilotinib
3.33
uM
LJP5
1.0692 0.0554 1.0737 0.0539
Hs 578T Nilotinib
10
uM
LJP5
0.2486 0.0541 0.0280 0.0557
Hs 578T JNK-9L
0.04
uM
LJP6
1.0082 0.0269 1.0121 0.0245
Hs 578T JNK-9L
0.12
uM
LJP6
1.0080 0.0254 1.0118 0.0256
Hs 578T JNK-9L
0.37
uM
LJP6
0.8707 0.0385 0.8762 0.0260
Hs 578T JNK-9L
1.11
uM
LJP6
0.5679 0.1122 0.5253 0.1071
Hs 578T JNK-9L
3.33
uM
LJP6
0.2707 0.0784 0.0520 0.0899
Hs 578T JNK-9L
10
uM
LJP6
0.1938 0.0422 -0.0974 0.0401
Hs 578T PD0325901
0.04
uM
LJP5
0.5624 0.0148 0.5184 0.0550
Hs 578T PD0325901
0.04
uM
LJP6
0.5584 0.0181 0.5070 0.0581
Hs 578T PD0325901
0.12
uM
LJP5
0.4743 0.0272 0.4056 0.0267
Hs 578T PD0325901
0.12
uM
LJP6
0.4758 0.0153 0.3989 0.0427
Hs 578T PD0325901
0.37
uM
LJP5
0.4245 0.0447 0.3349 0.0130
Hs 578T PD0325901
0.37
uM
LJP6
0.4207 0.0422 0.3214 0.0149